100% Quality Guarantee
PhD-Level Technical Support
Key Features

Uliledlimab Biosimilar (CD73) Antibody (HDBS0107)

SKU HDBS0107
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CD73
Reactivity Human
Host Species Humanized
Isotype IgG1
$569

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Uliledlimab Biosimilar (CD73) Antibody (HDBS0107)

The ULILEDlimab Biosimilar CD73 Antibody is a cutting-edge tool for researchers investigating the role of CD73, an important cell surface enzyme involved in immune regulation and cancer progression. This antibody, developed as a biosimilar to the well-known CD73 antibody ULILED, has been optimized for maximum specificity and sensitivity in binding to the CD73 protein in human samples.By targeting CD73, researchers can explore its functions in immune suppression, adenosine production, and tumor microenvironment modulation. The ULILEDlimab Biosimilar CD73 Antibody is ideal for use in Western blotting, immunohistochemistry, and flow cytometry applications, allowing for comprehensive analysis of CD73 expression and localization in various cell types and tissues.

With its high reactivity and validation for specific research applications, this antibody is a valuable tool for studies in immunology, oncology, and drug development. Understanding the mechanisms of CD73 activity and its role in disease pathology is essential for developing targeted therapies against cancer, inflammatory disorders, and other conditions where CD73 dysregulation plays a significant role.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose